About MicroRx Infectious Disease Supercluster Personnel Contact Information Advisory Northern Colorado Infectious Disease Research Colorado Bioscience MicroRx Brochure Partnering Featured Research Emerging Pathogen Threats Food Safety Mycobacterial Disease Vector-borne Disease Resources Animal Models Product Development and Manufacturing Research Innovation Center Rocky Mountain Regional Center for Excellence Infectious Disease Research Center For Researchers CSU Superclusters Activities MicroRx Cluster Leaders NeoTREX - Cancer Research CENERGY - Clean Energy Technology Transfer Process Legal Agreements CDA's Consulting IDF Hybridoma Development Agreement Contact Us Email Registration General Inquiry

MicroRx Technologies             Title of Technology           Compare all tuberculosis technology summaries in PDF format.                 Differentiating Multiplex Assay for Listeria                 Rice Blight Genomic Diagnostic                 Immuno-Antimicrobial Therapy for Infection                 Menaquinone A Inhibitors: Anti Mycobacterial Agents                 Serodiagnostic Antigens for Tuberculosis                 A Toll Receptor 2 Directed TB Vaccine                 Acid and Base Stable Esters: New Linkers for Solid-Phase Organic Synthesis (Synthesis or Libraries)                 Transferrin Receptor and Ferritin Expression in Primary Lung Lesions of Tuberculosis                 A Drug-Sensitized Pseudomonas Aeruginosa Strain Useful for Drug Discovery                 Asymmetrically Substituted Thiourea Derivatives: Potential Anti-TB Therapeutic Agents                 Bovine Viral Diarrhea Virus (BVDV) Diagnostic for Early Detection of Infected Cows and Fetuses                 Early Detection of Tuberculosis Using Culture Filtrate Proteins of Mycobacterium tuberculosis in Serological Assays                 Blueport: Injectable Vaccine Portal                 Active Sampling Device for Estimating Total Aerosol Deposition in the Human Respiratory Tract

Copyright © 2007 MicroRx. All rights reserved.